A 35-year-old man with a history of seasonal rhinitis presents with acute onset of severe dyspnea, wheezing, and chest tightness 30 minutes after mowing his lawn. His peak expiratory flow (PEF) is 180 L/min (baseline 480 L/min), and oxygen saturation is 88% on room air. He has used his albuterol inhaler twice without improvement. What is the most appropriate next step in management?

Explanation

## Acute Asthma Exacerbation: Type I Hypersensitivity Management ### Clinical Recognition of Severity **Key Point:** This patient has an acute, severe asthma exacerbation triggered by allergen exposure (grass pollen during lawn mowing). **Red flags indicating severity:** - PEF reduced to 37% of baseline (180/480) — **severe obstruction** - SpO₂ 88% on room air — **hypoxemia** - Failure to respond to 2 doses of albuterol — **inadequate response to initial therapy** - Dyspnea at rest with wheezing ### Pathophysiology Asthma is a **Type I hypersensitivity** reaction: 1. Allergen (grass pollen) cross-links IgE on mast cells and basophils 2. Degranulation releases histamine, tryptase, leukotrienes (LTC₄, LTD₄, LTE₄), and prostaglandins 3. Bronchoconstriction, mucus secretion, airway edema, and eosinophil infiltration 4. Acute airway obstruction and V/Q mismatch → hypoxemia ### Stepwise Management of Acute Severe Exacerbation ```mermaid flowchart TD A[Acute asthma exacerbation]:::outcome --> B{SpO₂ < 90% or PEF < 50% baseline?}:::decision B -->|Yes| C[Oxygen to target SpO₂ ≥ 90%]:::action C --> D[Albuterol via continuous nebulization]:::action D --> E[Add ipratropium bromide]:::action E --> F[IV or oral corticosteroids]:::action F --> G{Response in 1 hour?}:::decision G -->|Yes| H[Continue therapy, admit if needed]:::action G -->|No| I[IV magnesium sulfate, consider ICU]:::urgent B -->|No| J[Intermittent albuterol + oral steroids]:::action ``` ### Rationale for Correct Answer **High-Yield:** The correct approach is **simultaneous multi-drug therapy**: | Component | Rationale | |-----------|----------| | **Oxygen** | Maintain SpO₂ ≥ 90% to prevent hypoxemia-induced arrhythmias and end-organ damage | | **Albuterol (continuous)** | β₂-agonist causes bronchial smooth muscle relaxation; continuous nebulization delivers higher doses faster than intermittent dosing | | **Ipratropium** | Anticholinergic agent; blocks M₃ receptors on airway smooth muscle; synergistic with β₂-agonists in acute exacerbations | | **IV Corticosteroids** | Reduce airway inflammation, mucus production, and eosinophil infiltration; onset 4–6 hours; critical for preventing relapse | **Clinical Pearl:** Ipratropium is NOT a substitute for albuterol — it is an **adjunct** in severe exacerbations. The combination of albuterol + ipratropium is more effective than either alone. **Mnemonic:** **OAIC** for acute asthma: - **O**xygen - **A**lbuterol (continuous) - **I**pratropium - **C**orticosteroids (IV preferred in severe cases) ### Monitoring - Reassess PEF and SpO₂ after 1 hour - If no improvement: consider IV magnesium sulfate, IV theophylline, or ICU admission - Admit if PEF remains < 40% of baseline or SpO₂ < 90% despite therapy **Warning:** ~~Oral prednisone alone~~ without oxygen, bronchodilators, and continuous monitoring is insufficient for severe exacerbations — it delays critical therapy and increases risk of respiratory failure.